Prosonix Limited Report issue

For profit Phase 2
Founded: Oxford United Kingdom (2006)
Status: Acquired by Circassia Limited (2015)

Organization Overview

First Clinical Trial
2013
NCT01703624
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Prosonix Limited, Oxford, UK